Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Clinical trial NCT06590896 · RECRUITING

Trial details

NCT number: NCT06590896
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epilepsies, Partial

Start date: 2022-11-04
Primary completion: 2027-01-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.